President & Co-Founder
Beginning with David Schiller’s hiring as a Special Agent in 1987, he was involved in investigating some of the largest drug trafficking organizations throughout the world. In 2009, Schiller was reassigned as the Assistant Special Agent in Charge (ASAC) for the Denver Field Division. In this capacity he led all the criminal, administrative, and civil investigations affecting all DEA’s Registrants, including manufacturers, distributors, pharmacies, hospitals, narcotic treatment providers, and doctors. In 2015, Schiller was selected to be the Vice Chair of DEA’s Diversion Field Advisory Committee with ultimate responsibility for coordinating all Diversion related matters for every one of DEA’s 21 Field Divisions. He ended his career by finalizing the largest administrative and civil settlement against a DEA Registrant in the history of the DEA – the McKesson Corporation. Schiller was featured on 60 Minutes on December 17, 2017. Subsequent to his retirement in 2017, he co-founded NarcX. NarcX is the first and only independently-validated method of on-site destruction in the United States for prescription drugs as well as illicit drugs to include Heroin, Cocaine, Methamphetamine, and CBD Oil. NarcX was created for every household (ultimate-user) in the United States, every Hospice/Long Term Care Facility, as well as for every one of DEA’s 1.7 million Registrants.